NewResearch Grade
Cartalax
Cartilage & connective tissue regeneration
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed by the St. Petersburg Institute of Bioregulation and Gerontology. It is a bioregulator peptide designed to restore and normalise the function of cartilage and connective tissue, with research demonstrating effects on chondrocyte proliferation, collagen synthesis, and joint health in ageing models.
- ✓Stimulates chondrocyte proliferation & repair
- ✓Supports collagen synthesis in cartilage
- ✓Studied for osteoarthritis & joint degeneration
- ✓Bioregulator peptide from Russian longevity research
- ✓≥99% purity — HPLC verified
Mechanism of Action
Cartalax is a synthetic tetrapeptide that stimulates chondrocyte proliferation and extracellular matrix synthesis in cartilage tissue. Research indicates it promotes collagen type II and proteoglycan production, supporting cartilage regeneration models. It is structurally related to Epithalon and shares some gene-regulatory properties.
For research and educational purposes only. This information is derived from published preclinical and clinical literature and does not constitute medical advice.